Here are relevant reports on : brain-health-market
-
Europe Healthcare Analytics Market by Type (Predictive, Diagnostic), Application (Claim, RCM, Fraud, Precision Health, RWE, Imaging, Supply Chain, Population Health), End User (Payer, Hospital, ASC) Market Size, Opportunities, Trends - Forecast to 2030
The Europe healthcare analytics market, valued at US$14.17 billion in 2024, stood at US$17.47 billion in 2025 and is projected to advance at a resilient CAGR of 23.9% from 2024 to 2030, culminating in a forecasted valuation of US$50.91 billion by the end of the period. This has driven the demand for analytics solutions that can better facilitate clinical decision-making, operational efficiency, and value-based healthcare delivery within the healthcare system in Europe.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Ergometers Market by Product (Ergometer treadmills, Ergometer bikes, Ergometer rowing, & others), Application (Sports & Health), End User (Hospitals& Private Clinics, Health clubs/ Gyms, Home consumers, & others) - Global Forecast to 2023
The global ergometers market is expected to reach USD 1.2 billion by 2023 from USD 1.1 billion in 2018, growing at a CAGR of 2.3%. Increasing awareness about fitness and sports, increasing per capita expenditure, and technological advancements are some of the factors driving the demand for ergometer market.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Plant-based Beverages Market by Source (Almond, Soy, Coconut, and Rice), Type (Milk and Other Drinks), Function (Cardiovascular health, Cancer prevention, Lactose intolerance, and Bone health) and Region - Global Forecast to 2023
The global plant-based beverages market is estimated to be valued at USD 11.16 billion in 2018 and is projected to reach USD 19.67 billion by 2023, at a CAGR of 12.0% during the forecast period. Plant-based beverages provide consumers with options that are low in cholesterol and calories. The growth of the market is attributed to the shift in preference towards vegan diets among consumers at a global level. Apart from this, major food companies such as Danone (US) have been showing interest in plant-based beverages; this is expected to give the market a boost. This report includes a study of marketing and development strategies, along with the product portfolios of leading companies. It includes the profiles of leading companies such as The WhiteWave Foods Company (US), Blue Diamond Growers (US), Pacific Foods (US), Hain Celestial (US), SunOpta (Canada), Want Want China Holdings Limited (China), Kikkoman(Japan), Califia Farms (US), The Coca-Cola Company (US), Ripple Foods (US), WildWood Organic (US), and Pureharvest (Australia).
- Published: October 2018
- Price: $ 4950
- TOC Available:
-
Cognition and Memory Enhancement Market by Product & Service (Cognition & Memory-enhancing Drugs, Brain-boosting Nutraceuticals, Cognitive Assessment & Training Solutions), Region (North America, Europe, Asia Pacific, ROW) - Global Forecast to 2026
The global cognition enhancement market is expected to grow from USD 23.4 billion in 2021 to USD 38.9 billion by 2026, at a compound annual growth rate (CAGR) of 10.7% during the forecast period.The leading players Eisai Co., Ltd. (Japan), Johnson & Johnson Services, Inc. (US), Biogen Inc. (US), Eli Lilly and Company (US), Nordic Naturals (US), Natrol, LLC (US), Cambridge Cognition Ltd. (UK), and Cogstate Ltd. (US).
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Medical Bionic Implant /Artificial Organs Market - (Vision Bionics/Bionic Eye, Brain Bionics, Heart Bionics/Artificial Heart, Orthopedic Bionics and Ear Bionics) – Trends and Global Forecasts to 2017
Bionics is mechanical/electronic replacement or enhancement of organs/parts of living organisms. The medical bionic implants market is a potentially growing one with a global market of $12.67 billion in 2012. It is expected to grow at a CAGR of 7.1% to reach $17.82 billion in 2017.
- Published: November 2012
- Price: $ 4950
- TOC Available:
-
Neurostimulation Market by Product & Applications (2012-2017) (Spinal Cord, Deep Brain, Sacral Nerve, Vagus Nerve, Transcranial Magnetic, Gastric, TENS) Global Trends, Emerging Applications & Competitive Landscape
This report provides an in-depth review of the numerous significant developments in neurostimulation technology, and the markets for this technology. It also provides in detail the competitive landscape, profiles of key players and over 100 market related tables on the neurostimulation sector.
- Published: September 2009
- Price: $ 4950
- TOC Available:
-
Neuromodulation Market by Technology (Internal, External), Stimulation Type (Spinal Cord, Deep Brain, Vagus Nerve Stimulation), Application (Ischemia, Depression, Epilepsy, Obesity), End User (Hospitals, ASCs, Clinics) & Region - Global Forecast to 2030
The global neuromodulation market, valued at US$6.26 billion in 2024, stood at US$6.81 billion in 2025 and is projected to advance at a resilient CAGR of 9.4% from 2025 to 2030, culminating in a forecasted valuation of US$10.68 billion by the end of the period. Neuromodulation is increasingly recognized as an effective method for managing chronic conditions and improving patients’ quality of life.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Multimodal Imaging Market by Technology (PET-CT, SPECT-CT, PET-MR, OCT/FMT), Application (Oncology, Cardiology, Brain, Ophthalmology), End User (Hospitals, Diagnostic Centers, Academia, Research) & Region - Global Forecast to 2028
The global multimodal imaging market, valued at US$3.9 billion in 2022, stood at US$4.2 billion in 2023 and is projected to advance at a resilient CAGR of 5.7% from 2023 to 2028, culminating in a forecasted valuation of US$5.5 billion by the end of the period.
- Published: August 2023
- Price: $ 4950
- TOC Available:
-
Cognitive Assessment and Training in Healthcare Market by Assessment Type (Pen-and-Paper Based, Hosted, and Biometrics), Components, Application (Clinical Trial, Screening & Diagnostics, Brain Training, Academic Research), & Region - Global forecast to 2021
Cognitive impairment can occur in early childhood or late adulthood. There are various reasons for it, which can be reversible or irreversible. Early causes may include malnutrition, prenatal drug exposure, genetic syndromes, and chromosome abnormalities. The brain retains its neuroplasticity till late adulthood; therefore, there has been a growing demand for cognitive assessment and training. MarketsandMarkets predicts the global cognitive assessment and training in healthcare market to grow from USD 962.0 Million in 2016 to USD 4,127.2 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 33.8%. The year 2015 has been considered as the base year, while the forecast period is 2016–2021.
- Published: February 2017
- Price: $ 4950
- TOC Available:
-
Neurosurgery Devices Market by Product (Neuromodulation(Spinal Cord Stimulation, Deep Brain Stimulation) Neuroendoscopy), Application (Chronic Pain, Depression, Parkinsons, Ischemia, Transnasal Neuroendoscopy), Region - Global Forecast to 2024
The Neurosurgery Devices Market is expected to grow from USD 7.3 billion in 2019 to USD 13.5 billion by 2024, at a CAGR of 13.0% during the forecast period. Major players operating in the neurosurgery devices market include B. Braun Melsungen (Germany), Medtronic (US), Boston Scientific Corporation (US), Nevro Corporation (US), KARL STORZ (Germany), Abbott (US), Ackermann Instrumente (Germany), Hawk (China), Machida Endoscope (Japan), and adeor Medical (Germany).
- Published: September 2019
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
